Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects.
Cortellino S, Raveane A, Chiodoni C, Delfanti G, Pisati F, Spagnolo V, Visco E, Fragale G, Ferrante F, Magni S, Iannelli F, Zanardi F, Casorati G, Bertolini F, Dellabona P, Colombo MP, Tripodo C, Longo VD.
Cortellino S, et al. Among authors: colombo mp.
Cell Rep. 2022 Aug 23;40(8):111256. doi: 10.1016/j.celrep.2022.111256.
Cell Rep. 2022.
PMID: 36001966
Free article.